MyFinsight
Home
Blog
About
Contact
Investment securities,
amortized cost of 979,147...
$1,176,965K
Cash and cash
equivalents
$114,341K
Prepaid expenses and
other current assets
$22,361K
Trade accounts
receivable, net
$5,683K
Inventory
$3,064K
Total current assets
$1,322,414K
Operating lease
right-of-use assets
$39,790K
Prepaid expenses and
other assets, net of...
$24,822K
Property and equipment,
net
$13,497K
Restricted cash, net of
current portion
$800K
Total assets
$1,401,323K
Total liabilities and
stockholders equity
$1,401,323K
Total stockholders
equity
$1,280,646K
Total liabilities
$120,677K
Accumulated deficit
-$1,545,272K
Accumulated other
comprehensive (loss) income
-$1,254K
Stock held in trust
$1,032K
Common stock and
paid-in capital, 0.001...
$2,828,204K
Total current
liabilities
$71,086K
Operating lease
liabilities, non-current
$41,319K
Other liabilities
$4,926K
Deferred revenue,
non-current
$3,346K
Accounts payable and
accrued expenses
$37,487K
Accrued compensation
and related...
$25,792K
Operating lease
liabilities
$6,536K
Deferred revenue
$1,271K
Back
Back
Balance Sheet
Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX)
source: myfinsight.com